文献速递呼吸道感染呼吸危重症与机械通气

USP4通过稳定IQGAP1调控肺部炎症中的中性粒细胞铺展

USP4 controls neutrophil spreading through stabilising IQGAP1 during lung inflammation.
PubMed 文献 · Thorax · 2026-07-09

该研究在免疫特异性USP4敲除嵌合小鼠的急性肺损伤模型中,结合CyTOF、定量蛋白质组学与中性粒细胞功能实验,阐明USP4去泛素化并上调IQGAP1,增强CDC42活性与F-actin形成,从而促进中性粒细胞铺展和肺部炎症浸润;USP4抑制剂Vialinin A可减轻小鼠肺损伤并改善生存。

要点

  • USP4在ARDS患者及ALI小鼠血液和肺白细胞中表达上调,在肺实质中下调。
  • USP4通过去泛素化稳定IQGAP1,增强CDC42活性与F-actin形成,促进中性粒细胞铺展。
  • USP4抑制剂Vialinin A减轻ALI小鼠中性粒细胞浸润、改善肺功能与生存。

核心结论

  • USP4将蛋白稳态与炎症中的中性粒细胞募集联系起来。
  • 靶向USP4-IQGAP1轴(如Vialinin A)是重症肺炎继发ARDS的潜在治疗策略。

研究设计与样本

  • 建立免疫特异性USP4敲除嵌合(BM-Usp4-/-)与对照(BM-WT)小鼠的急性肺损伤模型。
  • 采用CyTOF质谱流式、定量蛋白质组学、免疫沉淀-质谱及中性粒细胞功能实验。

主要发现

  • USP4在ARDS患者及ALI小鼠血液和肺白细胞中表达上调(p=0.049,p=0.0086),在小鼠肺实质中下调(LPS vs 对照,p=0.0019)。
  • BM-Usp4-/-小鼠肺损伤减轻、中性粒细胞浸润减少(肺组织p<0.0001,BALF p=0.0056 vs BM-WT)。
  • Usp4-/-中性粒细胞铺展比例和面积均减少(p<0.0001 vs Usp4+/+)。
  • USP4去泛素化并上调IQGAP1,增强CDC42活性(p=0.0286)与F-actin形成(p<0.0001)。
  • 重症肺炎患者中USP4与IQGAP1表达正相关(p=0.0438,R²=0.7898);Vialinin A在ALI小鼠中减少中性粒细胞浸润、改善肺功能与生存、缓解肺损伤进展。

临床怎么用

  • USP4-IQGAP1轴可作为重症肺炎继发ARDS的潜在干预靶点。
  • Vialinin A在ALI小鼠中显示减轻中性粒细胞浸润和改善预后的作用,尚需临床验证。

局限性

  • 机制与疗效证据主要来自小鼠ALI模型及体外中性粒细胞实验,人体数据为相关性观察。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Protein availability critically influences innate immune reactivity and the extent of immune-mediated tissue injury. A key unresolved question is how specific protein homeostasis networks within immune cells such as neutrophils can be modulated to mitigate the detrimental outcomes of acute inflammation. METHODS: We established an acute lung injury (ALI) model in immune-specific ubiquitin-specific peptidase 4 (USP4) knockout chimeric (BM-Usp4-/-) and control (BM-WT) mice. Using cytometry by time-of-flight (CyTOF) mass cytometry, quantitative proteomics, immunoprecipitation-mass spectrometry and neutrophil functional assays, we elucidated the molecular mechanism of USP4 in a specific neutrophil migratory behaviour-spreading-as well as the therapeutic potential of USP4 inhibitors in acute respiratory distress syndrome (ARDS). RESULTS: USP4 expression was upregulated in blood and pulmonary leucocytes from patients with ARDS and ALI mice (p=0.049, p=0.0086), but downregulated in mouse lung parenchyma (lipopolysaccharide vs control, p=0.0019). BM-Usp4-/- mice exhibited attenuated lung injury and neutrophil infiltration (in lung tissue and bronchoalveolar lavage fluid, p<0.0001 and p=0.0056 vs BM-WT). Usp4-/- neutrophils showed a reduction in both the proportion and area of spreading (p<0.0001 vs Usp4+/+neutrophils). Mechanistically, USP4 deubiquitinated and upregulated IQGAP1, enhancing CDC42 activity (p=0.0286) and F-actin formation (p<0.0001). Notably, USP4 and IQGAP1 expression correlated positively for patients with severe pneumonia (p=0.0438, R²=0.7898). Moreover, USP4 inhibitor Vialinin A in ALI mice decreased neutrophil infiltration, improved lung function and survival and alleviated lung injury progression. CONCLUSION: USP4 links protein homeostasis to neutrophil recruitment during inflammation. Targeting the USP4-IQGAP1 axis with Vialinin A represents a promising therapeutic strategy for patients with ARDS secondary to severe pneumonia.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Meng L, He Q, Chen S, et al. USP4 controls neutrophil spreading through stabilising IQGAP1 during lung inflammation. Thorax. 2026. PMID: 42425898. doi:10.1136/thorax-2026-224871

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。